Anti-KAAG1 (ADCT-901-MMAE)
Anti-KAAG1 (ADCT-901-MMAE) is an ADC composed of a humanized monoclonal antibody (3A4) targeting human KAAG1. It is used for the treatment of advanced solid tumors including platinum resistant ovarian cancer and triple negative breast cancer. MW :145.28 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A3153 |
| Sku # | A3153-1mg*5 |
| Pricing | 1mg*5, $1690.00 |